×
New! See the top 50 exchanges ranked by liquidity metric
We just launched Liquidity to combat the volume inflation problem. More info here!
×
Mga Cryptocurrency:  4,844Mga Market:  20,809Market Cap:  $220,158,432,01524h Dami:  $66,231,306,472Dominance ng BTC:  65.8%
Market Cap:  $220,158,432,01524h Dami:  $66,231,306,472Dominance ng BTC:  65.8%Mga Cryptocurrency:  4,844Mga Market:  20,809

Maecenas (ART)

$0.027040 USD (-30.85%)
0.00000337 BTC (-29.26%)
0.00015406 ETH (-30.09%)
Bumili
Palitan
Crypto Credit
  • Market Cap
    $1,578,123 USD
    196.66529621 BTC
    8,991 ETH
  • Dami (24 na oras)
    $861.72 USD
    0.10738673 BTC
    4.90961209 ETH
  • Umiikot na Supply
    58,362,990 ART
  • Kabuuang Supply
    100,000,000 ART
  • Sagad na Supply
    100,000,000 ART

Tungkol sa Maecenas

Maecenas (ART) is a cryptocurrency token and operates on the Ethereum platform. Maecenas has a current supply of 100,000,000 with 58,362,989.91 in circulation. The last known price of Maecenas is $0.027040 USD and is down -30.85% over the last 24 hours. It is currently trading on 6 active market(s) with $861.72 traded over the last 24 hours. More information can be found at http://www.maecenas.co/.

Estadistika ng Maecenas

Maecenas Price
$0.027040 USD
Maecenas ROI
-92.09%
Ranggo sa Merkado
#756
Market Cap
$1,578,123 USD
Dami sa loob ng 24 Oras
$861.72 USD
Umiikot na Supply
58,362,990 ART
Kabuuang Supply
100,000,000 ART
Sagad na Supply
100,000,000 ART
Pinakamataas
$2.58 USD
(Jan 10, 2018)
Pinakamababa
$0.007718 USD
(Dec 30, 2018)
52 Linggong Mataas / Mababa
$0.245097 USD /
$0.007718 USD
90 Araw na Mataas / Mababa
$0.097106 USD /
$0.017288 USD
30 Araw na Mataas / Mababa
$0.052953 USD /
$0.018993 USD
7 Araw na Mataas / Mababa
$0.042132 USD /
$0.024987 USD
24 Oras na Mataas / Mababa
$0.038974 USD /
$0.024987 USD
Mataas / Mababa Kahapon
$0.040610 USD /
$0.024987 USD
Pagbubukas / Pagsasara Kahapon
$0.040451 USD /
$0.027032 USD
Pagbabago Kahapon
$-0.013419 USD (-33.17%)
Dami Kahapon
$868.37 USD
Sign up for our newsletter
Get crypto analysis, news and updates, right to your inbox! Sign up here so you don't miss a single one.